AstraZeneca in touch with Indian authorities for COVID drug Evusheld Ruchika Sharma10 Dec 2021 2:34 PM ISTEvusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US for COVID-19 pre-exposure...
Former Religare CEO arrested for siphoning off Rs 2397 crore fund Ruchika Sharma10 Dec 2021 1:33 PM ISTNew Delhi: A Delhi court on Thursday sent Krishnan Subramanian, former CEO of Religare Enterprises Limited (REL), to judicial custody for four days in...
Dr Reddys, Prestige BioPharma ink pact for Trastuzumab biosimilar commercialization in select countries Ruchika Sharma10 Dec 2021 1:24 PM ISTSingapore: Prestige BioPharma Ltd. and Dr. Reddy's Laboratories Ltd. have announced that the two companies have entered into a binding agreement for...
Dr SS Jadhav, who helped develop Serum Institute Covishield no more MD Bureau9 Dec 2021 3:24 PM ISTPune: Eminent scientist and Executive Director of Serum Institute of India (SII) Dr Suresh S. Jadhav - who was instrumental in developing the...
Covid-19: Indian vaccine makers bank on boosters as demand crashes Ruchika Sharma9 Dec 2021 2:58 PM ISTNew Delhi: Indian Covid-19 vaccine makers are lobbying the government to authorise boosters as supplies have so outstripped demand that one drugmaker...
Vineet Gupta appointed as GM of Eli Lilly India affiliate Ruchika Sharma9 Dec 2021 1:25 PM ISTNew Delhi: Eli Lilly and company (India) has announced the appointment of Vineet Gupta as the General Manager of its India subsidiary with effect...
AstraZeneca COVID antibody cocktail authorized by USFDA Ruchika Sharma9 Dec 2021 1:24 PM ISTUK: AstraZeneca has recently announced that Evusheld (tixagevimab co-packaged with cilgavimab), a Long-Acting Antibody (LAAB) combination, has...
Two dose vaccine effective against COVID, claims Canadian drugmaker Ruchika Sharma9 Dec 2021 10:00 AM ISTOttawa: A Canadian drugmaker said its plant-based COVID-19 vaccine showed strong protection against the virus and will soon seek authorization at home...
Serum Institute to slash Covishield production by 50 percent amid demand slump Ruchika Sharma8 Dec 2021 5:39 PM ISTNew Delhi: With not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking...
BDR Pharma launches India's first generic cancer treatment drug Midostaurin Ruchika Sharma8 Dec 2021 4:20 PM ISTBDR Pharma has launched the country's first generic Midostaurin under the brand name MSTARIN to treat cancer.
Alembic Pharma gets USFDA nod for pulmonary arterial hypertension drug Selexipag Ruchika Sharma8 Dec 2021 3:14 PM ISTMumbai: Drugmaker, Alembic Pharmaceuticals Limited, today announced that the company has received tentative approval from the US Food & Drug...
SPARC licenses PDP-716, SDN-037 drug rights to Visiox Pharma Ruchika Sharma8 Dec 2021 1:20 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced that the company has entered into an agreement with Visiox Pharma LLC...
